There may be changes to a study due to COVID-19 restrictions. Please reach out to the study coordinators at 202-476-6067 with specific questions.
Psychiatry Clinical Trials at Children’s National Hospital are conducted by Adelaide Robb, M.D. Dr. Robb has been participating in pediatric clinical trials since 1999. These studies include treatments for a variety of mental health conditions affecting kids and teens, such as depression, ADHD, schizophrenia and bipolar disorder.
Interested in participating?
If you are interested in having your child participate in psychiatry research now or in the future please provide your contact information. One of our study coordinators will reach out to you with more information.
Currently Enrolling Clinical Trials
NCT05523895
6-week, randomized, double-blind, fixed-dose, placebo-controlled, parallel group study in children and adolescents (aged 5 to 17 years) with autism spectrum disorder (ASD) with irritability, agitation, or self-injurious behaviors to study the efficacy and safety of pimavanserin.
This study looks at the efficacy and safety of the investigational medicine pimavanserin, a potential treatment for Irritability associated with autism spectrum disorder (ASD) in children ages 5 to 17.
- Investigator: Adelaide Robb, M.D.
- Sponsor: Acadia Pharmaceuticals
Full study details on ClinicalTrials.gov.
NCT04240756
Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial (TPAC)
This study will compare the effectiveness of treating a parent with ADHD medication plus behavioral parent training (BPT) versus BPT alone on their child’s ADHD related symptoms.
- Investigator: Adelaide Robb, M.D.
- Sponsor: NIH